ArticleFrontiers in pharmacology2022

Corrigendum: Honokiol ameliorates post-myocardial infarction heart failure through Ucp3-mediated reactive oxygen species inhibition.

Jianyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.